journal article·2016-05

Smectite as ciprofloxacin delivery system: Intercalation and temperature-controlled release properties

A. Rivera, L. Valdés, J. Jiménez, I. Pérez, A. Lam, E. Altshuler, L.C. de Ménorval, J.O. Fossum, E.L. Hansen, Z. Rozynek

Applied Clay Science· Volume 124-125
Publisher page

Abstract

Abstract Clays have shown to be good candidates as drug delivery carriers. In the present paper, the temperature-dependent swelling of smectites was exploited to obtain composites able to release a drug in a controlled way. More specifically, synthetic fluorohectorite-ciprofloxacin composites were prepared, in which the drug molecules were intercalated between the clay layers. The drug-release systems were characterized by X-ray diffraction (XRD), infrared spectroscopy (IR), thermal gravimetric analysis (TGA), ultraviolet spectroscopy (UV) and atomic absorption spectrometry (AAS). The results from the X-ray diffraction allowed confirming the ciprofloxacin incorporation into the interlayer space, and the results from UV spectroscopy indicated that more than 90% of the initial drug was uptaken by the clay. The thermally activated drug release from a colloidal dispersion of nanosized composite particles in both pure water and synthetic gastric juice was evaluated at temperatures from 37 °C (body temperature) to 85 °C. The studies indicated that the clay promotes the slow release of ciprofloxacin, and that the release of drug increases with both time and temperature. The profiles of drug-release from the clay fulfilled the pharmaceutical standards for these systems. As a result, a clay-based Temperature-Controlled Release System (TCRS) with potential biomedical applications has been obtained.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Layered Double Hydroxides Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Clay swelling – a challenge in the oilfield10.1016/j.earscirev.2009.11.003 ↗
2. Protein stabilization by salt bridges: concepts, experimental approaches and clarification of some misunderstandings10.1002/jmr.657 ↗
3. Pharmaceutical nanotechnology montmorillonite nanodevices for the colon metronidazole delivery10.1016/j.ijpharm.2013.09.017 ↗
4. Clay minerals and their beneficial effects upon human health10.1016/S0169-1317(01)00085-0 ↗
5. Surface diffusion of adsorbed molecules in Porous Media: monolayer, multilayer, and capillary condensation regimes10.1021/ie010195z ↗
6. Structure characterization and spectroscopic investigation of ciprofloxacin drug10.1007/s10973-011-1584-8 ↗
7. Cations as mediators of the adsorption of nucleic acidson clay surfaces in prebiotic environments10.1023/A:1023982008714 ↗
8. Sorption of the antimicrobial ciprofloxacin to aluminum and iron hydrous oxides10.1021/es051109f ↗
9. Formulation and antibacterial profiles of clay–ciprofloxacin composites10.1016/j.clay.2013.10.020 ↗
10. Swelling transition of a clay induced by heating10.1038/srep00618 ↗
11. X-ray studies of interlayer water absorption and mesoporous water transport in a weakly hydrated clay10.1103/PhysRevE.82.036315 ↗
12. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against Gram-positive and Gram-negative pathogens from respiratory tract infections10.1093/jac/40.3.427 ↗
13. Microscale polymer bottles corked with a phase-change material for temperature-controlled release10.1002/anie.201305006 ↗
14. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate10.1016/j.ijpharm.2009.03.004 ↗
15. Mesoporous synthetic hectorites: a versatile layered host with drug delivery application10.1016/j.micromeso.2010.12.040 ↗
16. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole10.1016/j.ijpharm.2007.08.008 ↗
17. Effect of chitosan on the release of protein from thermosensitive poly (organophosphazene) hydrogels10.1016/j.ijpharm.2007.08.010 ↗
18. Dielectric properties of smectite clays10.1016/S0022-3697(96)00076-5 ↗
19. Pore characteristics and water absorption in a synthetic smectite clay10.1107/S0021889803001778 ↗
20. Dissolution of hectorite in inoganic acids10.1346/CCMN.1996.0440208 ↗
21. Pharmaceutical and cosmetic applications of clays
22. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products10.1016/j.clay.2006.06.016 ↗
23. Preparation and infrared spectroscopic characterization of reduced-charge montmorillonite with various Li contens10.1180/claymin.1996.031.2.09 ↗
24. Anionic clays containing anti-inflammatory drug molecules: comparison of molecular dynamics simulation and measurements10.1021/jp050480m ↗
25. Vibrational spectroscopic characterization of fluoroquinolones10.1016/j.saa.2004.11.014 ↗
26. Removal of PCBs from wastewater using fly ash10.1016/S0045-6535(03)00517-4 ↗
27. Controlled release of donepezil intercalated in smectite clays10.1016/j.ijpharm.2008.04.012 ↗
28. Influence of types and charges of exchangeable cations on ciprofloxacin sorption by montmorillonite10.1007/s11595-012-0495-2 ↗
29. Clinoptilolite-surfactant composites as drug support: a new potential application10.1016/j.micromeso.2005.01.011 ↗
30. Dipolar structuring of organically modified fluorohectorite clay particles
31. Adsorption of promethazine hydrochloride with KSF montmorillonite10.1007/s10450-006-0141-4 ↗
32. Hydration transitions in a nanolayered synthetic silicate: a synchrotron X-ray scattering study10.1103/PhysRevB.67.094114 ↗
33. TEM and XRD study of early crystallization of lithium disilicate glasses10.1016/j.jnoncrysol.2003.08.075 ↗
34. The systems containing clays and clay minerals from modified drug release: a review10.1016/j.colsurfb.2012.10.068 ↗
35. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium10.1016/S0939-6411(02)00018-8 ↗
36. Preparation of a novel PEG–clay hybrid as a DDS material: dispersion stability and sustained release profiles10.1016/j.jconrel.2005.03.031 ↗
37. Spectroscopic investigation of ciprofloxacin speciation at the Goethite-Water interface10.1021/es061921y ↗
38. Crystal structure of ciprofloxacin hexahydrate and its characterization10.1016/S0378-5173(97)04913-2 ↗
39. USP30-NF25 (2007). The United States Pharmacopeial Convention Inc., Rockville, MD. Activated Attapulgite, 1467; Bentonite, 1066, 1067; Bentonite Magma 1068; Kaolin, 2436; Magnesium trisilicate 2536; Magnesium trisilicate tablets 2537; Ciprofloxacin Hydrochloride, 1756; Ciprofloxacin Tablets, 1759; Acetaminophen Tablets, 1269; Ibuprofen, 2325.
40. Uses of clay minerals in semisolid health care and therapeutic products10.1016/j.clay.2006.07.006 ↗
41. Current challenges in clay minerals for drug delivery
42. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro10.1128/AAC.28.4.581 ↗
43. Evaluating proteins release from, and their interactions with, thermosensitive poly (N-isopropylacrylamide) hydrogels10.1016/j.jconrel.2004.10.008 ↗